Back to Trades
Stazzone Peter
Chief Financial OfficerCIK 0002083297
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 4 filings between 2025–2026, Stazzone Peter, Chief Financial Officer, has disclosed $445.0K in transactions — all concentrated in LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Jul 2 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Stazzone Peter | Chief Financial Officer | Grant | $0 |
| Apr 17 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Stazzone Peter | Chief Financial Officer | Grant | $222.5K |
| Sep 4 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Stazzone Peter | Chief Financial Officer | Award | $222.5K |
| Sep 4 | LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Stazzone Peter | Chief Financial Officer | Other | $0 |
4 filings